RISE ABOVE UNCERTAINTY

Nick has ten years’ experience developing FDA-cleared diagnostic products and technologies, most recently serving four years as Director and Senior Director of the Advanced Technology Group at Luminex Corporation. He also chaired the company’s Technology Advisory Board and led a team of executives in developing the company’s first technology roadmap. He has innovated across a number of technical disciplines, twice winning Luminex’s “Top Inventor” award (2009 & 2014). He has six issued patents and thirteen patents pending. Nick obtained his B.S. in Electrical Engineering from the University of Texas at Austin.

Bryan is a dual board certified physician and an entrepreneur. He runs two successful businesses, has published over 30 original articles and abstracts in peer-reviewed scientific journals, and has been asked to lecture both nationally and internationally for his research. Bryan received his Bachelor of Science in electrical engineering from the University of Texas at Austin, his medical degree from the University of Texas Southwestern, and his MBA from UCLA. He completed his dermatology residency at Northwestern University in Chicago, and his fellowship in dermatopathology at Stanford University.

Patrick J. Balthrop is Chairman of the Board at Agendia and Folio Conversant and Director at Oxford Immunotec Global, Personalis, Inc. and Concert Genetics. He is an advisor to Water Street Healthcare Partners and the Founding Principal of Apalachee Ventures, an investment and advisory firm. Pat previously served as President and CEO of Luminex Corporation from 2004 until his retirement in 2014. Under his leadership, Luminex grew from $30 million in revenue to more than $200 million and was honored by Forbes and Fortune as one the fastest growing technology companies in America. Prior to Luminex, Pat served as President at Fisher Healthcare (then Fisher Scientific) and held a number of positions within Abbott Laboratories, including President of Abbott Vascular and Corporate VP, Worldwide Commercial Operations. Pat obtained an MBA from Northwestern University and a BS in Biology from Spring Hill College.

Greg is Vice President of Concorde Companies and Managing Director at Omnimed Capital, a Concorde subsidiary that specializes in healthcare investments, representing Omnimed on the Klaris Board of Directors. Prior to joining Concorde, Greg worked for JP Morgan underwriting debt financing for acquisitions, real estate transactions, and lines of credit for middle market companies in and around Texas. He also serves on the Endowment Foundation Investment Committee for the Children’s Oncology Service of Texas (aka the Ronald McDonald House). Greg graduated from the University of Texas at Austin and earned an MBA from Southern Methodist University.

Bud recently served as Chairman of the Board of Gentherm Incorporated. Under his leadership, Gentherm grew from a small pre-revenue company into a multinational corporation with more than 11,000 employees and $1 billion in annual revenue. Before Gentherm, he was President and CEO, TMW Enterprises, Chairman of Board, GT Automotive, and President and CEO, Electro-Wire Products Inc. He served for 32 years in a variety of positions at Ford Motor Company, including Vice President, Automotive Components Group, President & General Manager, Ford of Mexico; and CFO, Ford Europe. Bud also served on the boards of Parametric Technology Corporation (NASDAQ) and TESMA International Inc. (NASDAQ, TSE). He graduated from Princeton University and earned an MBA in Finance from Northwestern University.

Nick has ten years’ experience developing FDA-cleared diagnostic products and technologies, most recently serving four years as Director and Senior Director of the Advanced Technology Group at Luminex Corporation. He also chaired the company’s Technology Advisory Board and led a team of executives in developing the company’s first technology roadmap. He has innovated across a number of technical disciplines, twice winning Luminex’s “Top Inventor” award (2009 & 2014). He has six issued patents and thirteen patents pending. Nick obtained his B.S. in Electrical Engineering from the University of Texas at Austin.

Ross is an expert in droplet microfluidics with seven years’ experience developing FDA-cleared products and technologies, most recently as a Senior Mechanical Engineer at Luminex Corporation. Ross won Luminex’s “Top Inventor” award in 2010, and again 2014 (as a co-inventor with Nick). He has one issued patent and four patents pending. Ross obtained an M.S. in Mechanical Engineering from the University of Texas at Austin and a B.S. in Mechanical Engineering with Honors from the University of New Mexico.

David joined Klaris Diagnostics as VP of Research & Development in June of 2017. He brings over 15 years’ of research and development experience. Prior to joining Klaris, David held leadership roles of increasing responsibility at Luminex. While at Luminex, he led teams responsible for product development across the maturity continuum from early technology assessment to commercialization. This included the launch of multiple regulated products (CE-IVD, IVD) in the US and abroad. David has also contributed to the development of advanced DNA sequencing technologies at Life Technologies and held a Distinguished Post-Doctoral Fellowship in the Center of Integrated Nanotechnologies at Los Alamos National Laboratory.

David holds a B.S. in Chemistry from the University of Nebraska with High Honors and a Ph.D. from the University of California at Santa Barbara.

Kyle joined Klaris Diagnostics as VP of Business Development & Marketing in April 2018. He brings deep clinical diagnostics industry expertise and over 15 years of experience in health technology strategy and commercialization. Kyle comes to Klaris from Luminex Corporation where he most recently served as Sr. Director, Global Strategic Marketing. There he developed numerous key partnership and led many aspects of the company’s strategic investments into its high-growth molecular diagnostics franchise. Prior to joining Luminex, Kyle held marketing, sales and consulting positions with Abbott Laboratories and Cerner Corporation.

Kyle holds a BS in Finance and a BA in Music from Truman State University and an MBA from the Kellogg School of Management at Northwestern University.

Matthew is an image and signal processing expert with 15 years software development experience, including 8 years within an FDA regulated environment. At Luminex, Matthew was the Technical Lead and primary developer responsible for signal and image processing. Mathew has 13 issued patents and 1 patent pending, winning Luminex’s “Top Inventor” award in 2011. Matthew obtained a B.S in Applied Mathematics with highest honors and a B.S. in Computer Science with highest honors, both from the Georgia Institute of Technology.

Jon joined Klaris Diagnostics as Principal Hardware Engineer in December 2017, bringing 19 years’ experience developing high-performance systems. Prior to joining Klaris, Jon was Principal Hardware Engineer at Ixia and Camera Lead at Polycom. He has been the lead engineer on four on-market products ranging from terabit-per-second communication systems to panoramic video conferencing systems and 3D viewable light-field displays. Jon holds a B.S. in Mechanical Engineering and a B.S. in Electrical Engineering from Rose-Hulman Institute of Technology.

Erin joined the Microbiology team at Klaris Diagnostics as a Senior Scientist in July 2018. She has more than 10 years’ experience in the characterization of bacterial strains, including identification and antibiotic susceptibility of blood-borne pathogens. Prior to joining Klaris Diagnostics, she worked on the development of a colorimetric system for the identification and antibiotic susceptibility of microorganisms at Specific Diagnostics. Erin also worked in strain development for production of bio-butanol from lignocellulosic feedstocks at Cobalt Technologies and held a Senior Postdoctoral Fellowship exploring cyclic-di-GMP signaling at the University of Washington.

Erin holds a B.S. from Purdue University and a Ph.D. from Baylor College of Medicine.

Coming Soon